About EndoChoice
EndoChoice is a Healthcare company based in Alpharetta (United States) founded in 2008, and was acquired by Boston Scientific in September 2016. Devices, systems, and services are provided for GI specialists. EndoChoice has raised $115.96 million across 7 funding rounds from investors including Boston Scientific, SVB and MidCap Financial. The company has 414 employees. EndoChoice has completed 1 acquisition, including Peer Medical. The company was acqui-hired. Its focus areas include Life Sciences, Gastroenterology, Medical Devices and Therapeutic Devices. Its legal entity is Endochoice Inc. Its competitors include EndoGastric Solutions, CoapTech and SafeStitch; 3 of its 3 listed competitors have raised funding.
Company details
EndoChoice was founded in 2008 and is based in Alpharetta, United States. Operations focus on the gastrointestinal sector, where devices, diagnostics, infection control measures, and imaging tools are supplied to specialists addressing GI conditions. A public listing on the stock exchange was completed in June 2015, supporting expansion in medical technology for digestive health.
- Headquarters Alpharetta, United States
- Employees 414
- Stage Public
- SectorsHealthcare
- Website endochoice.com
- Social LinkedIn X Facebook
- Acquired by Boston Scientific (Sep 2016)
- Legal Name Endochoice Inc
- Total Equity Funding$115.96M (USD)
in 7 rounds
- Latest Funding Round$58M (USD), Debt – Conventional
Jun 2015
- InvestorsBoston Scientific
& 9 more
- Employee Count414
- Investments & Acquisitions
- Acquired byBoston Scientific
(Sep 2016)
Funding Insights of EndoChoice
EndoChoice has successfully raised a total of $115.96M across 7 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $58 million completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $115.96M
- Total Rounds 7
- Last Round Debt – Conventional — $58M
- First Round $600,000
(May 2008)
- Investors Count 9
All 7 funding rounds of EndoChoice with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2015 | $58M | Debt – Conventional | – | – | |
| Mar 2015 | $57M | Series E | – | – | |
| Jan 2013 | $43M | Series D | – | – | |
| Jan 2011 | $4.49M | Series C | – | Council Capital, Envest Private Equity | – |
| Jun 2010 | $7.65M | Series C | – | – | – |
| Aug 2009 | $3.22M | Series B | – | Council Capital, Envest Private Equity | |
| May 2008 | $600,000 | Series A | – | – |
10 investors in total: 10 institutional.
Investors in EndoChoice
EndoChoice has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, SVB and MidCap Financial.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private debt funds are managed across multiple sectors. | 2008 | midcapfinancial.com | Bethesda, United States | |
Early-stage and late-stage biotech and finance companies are funded. | rockspringscapital.com | Baltimore, United States | ||
Sequoia Capital is engaged in venture capital investments. | 1972 | sequoiacap.com | ||
Healthcare ecosystem is supported through investment and innovation by Deerfield. | deerfield.com | New York, United States | ||
| accelmed.com | ||||
Council Capital is focused on healthcare investment and support. | 2000 | councilcapital.com | Nashville, United States | |
Long-term capital is invested in basic industry businesses. | envestcap.com | Virginia Beach, United States | ||
| rccf.com | ||||
Banking services are provided to innovative companies, investors, and individuals. | 1983 | svb.com | Santa Clara, United States | |
Wide range of medical devices | 1979 | bostonscientific.com | Marlborough, United States |
Investor details for EndoChoice
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EndoChoice
EndoChoice has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Peer Medical.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Gastrointestinal endoscopy technology for bowel cancer diagnosis was developed. | peer-medical.com | Tullamarine, Australia | 2009 | Jan 2013 | •••• |
Complete acquisition details for EndoChoice
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of EndoChoice
6 dated milestones of EndoChoice across 8 years, from founding to its latest funding, stage changes and deals.
- Founded EndoChoice is founded.
- Funding First funding round of $600K.
- Acquisition Acquires Peer Medical.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Debt – Conventional, of $58.0M.
- Exit Acquired by Boston Scientific.
Competitors of EndoChoice
EndoChoice has 3 listed competitors in our database, 3 of them funded. They include EndoGastric Solutions, CoapTech and SafeStitch.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| endogastricsolutions.com | 2002 | San Mateo, United States | $355.2M | 80 | Incisionless transoral procedures for upper GI diseases are developed. | |
| coaptech.com | 2016 | Baltimore, United States | $16.52M | Minimally invasive gastrostomy feeding tube placement method is developed. | ||
| safestitch.com | 2005 | Miami, United States | $7.58M | 167 | Medical devices for gastrointestinal and bariatric surgery are developed. |
Detailed competitors of EndoChoice
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of EndoChoice
Websites that share an audience with EndoChoice (endochoice.com).
Websites whose visitors overlap most with EndoChoice. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| corisbio.com | 100% | 1.2K | #12,451,780 | View details | |
| globusmedical.com | 94% | 77.8K | #437,693 | View details | |
| metsol.com | 91% | 7.5K | #2,775,139 | View details | |
hardmanpathology.com | hardmanpathology.com | 87% | – | ||
| greensboropathology.com | 86% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for EndoChoice
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Gastroenterology
3 companies that operate in the same segment as EndoChoice (Gastroenterology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for gastrointestinal disorders, including linaclotide, are developed. | 1998 | Cambridge, Massachusetts, United States | USD 206.25 M | USD 296.15 M | 253 | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | |||
Provider of a deep learning platform for detecting circulating cancer-related markers | 2014 | United States | USD 1.35 B | 411 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about EndoChoice
EndoChoice was founded in 2008.
EndoChoice is headquartered in Alpharetta, United States. It is registered at Alpharetta, Georgia, United States.
EndoChoice is a funded company, having raised a total of $115.96M across 7 funding rounds to date. The company's 1st funding round was a Series A of $600K, raised on May 2008.
EndoChoice has 414 employees.
EndoChoice was founded in 2008 and is based in Alpharetta, United States. Operations focus on the gastrointestinal sector, where devices, diagnostics, infection control measures, and imaging tools are supplied to specialists addressing GI conditions. A public listing on the stock exchange was completed in June 2015, supporting expansion in medical technology for digestive health.
EndoChoice's top competitors include CoapTech, EndoGastric Solutions and SafeStitch.
EndoChoice has made 1 acquisition, including Peer Medical.
EndoChoice has 10 investors. Key investors include Boston Scientific, SVB, MidCap Financial, Rock Springs Capital, and Sequoia Capital.
EndoChoice operates through Endochoice Inc.
Yes. EndoChoice was acquired by Boston Scientific in September 2016.